Treg fitness as a biomarker for disease activity in Juvenile Idiopathic Arthritis
Authors:
Preprint
Abstract
Juvenile Idiopathic Arthritis (JIA) is an autoimmune condition characterised by persistent flares of joint inflammation. However, no reliable biomarker exists to predict the erratic disease course. Normally, regulatory T cells (Tregs) maintain immune tolerance, with altered Tregs associated with autoimmunity. Treg signatures have shown promise in monitoring other autoimmune conditions, therefore a Treg gene and/or protein signature could offer novel biomarker potential for predicting disease activity in JIA. Machine learning on our nanoString Treg gene signature on peripheral blood (PB) Tregs generated a model to distinguish active JIA (active joint count, AJC≥1) Tregs from healthy controls (HC, AUC=0.9875). Biomarker scores from this model successfully differentiated inactive (AJC=0) from active JIA PB Tregs. Moreover, scores correlated with clinical activity scores (cJADAS), and discriminated subclinical disease (AJC=0, cJADAS≥0.5) from remission (AUC=0.8980, Sens=0.8571, Spec= 0.8571). To investigate altered Treg fitness in JIA by protein expression, we utilised spectral flow cytometry and unbiased analysis. Three Treg clusters were increased in active JIA PB, including CD226 high CD25 low effector-like Tregs and CD39-TNFR2-Helios high , while a 4-1BB low TIGIT low ID2 intermediate Treg cluster predominated in inactive JIA PB (AJC=0). The ratio of these Treg clusters correlated to cJADAS, and higher ratios could predict inactive individuals that flared by 6-month follow-up. Thus, we demonstrate altered Treg signatures and subsets as an important factor, and useful biomarker, for disease progression versus remission in JIA, revealing genes and proteins important in Treg fitness. Ultimately, PB Treg fitness measures could serve as routine biomarkers to guide disease and treatment management to sustain remission in JIA.Keywords
This publication has 63 references indexed in Scilit:
- Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic jointClinical & Translational Immunology, 2022
- Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritisClinical Rheumatology, 2022
- Integration, exploration, and analysis of high‐dimensional single‐cell cytometry data using SpectreCytometry Part A, 2021
- LAP+ Treg is a better biomarker than total Treg in viral myocarditisJournal of Medical Virology, 2018
- Self‐Sustained Resistance to Suppression of CD8+ Teff Cells at the Site of Autoimmune Inflammation Can Be Reversed by Tumor Necrosis Factor and Interferon‐γ BlockadeArthritis & Rheumatology, 2015
- Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid ArthritisArthritis & Rheumatology, 2015
- The inflammatory milieu in the rheumatic joint reduces regulatory T‐cell functionEuropean Journal of Immunology, 2011
- Digital Multiplexed Gene Expression Analysis Using the NanoString nCounter SystemCurrent Protocols in Molecular Biology, 2011
- Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in RemissionA Randomized Clinical TrialJAMA, 2010
- Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expressionArthritis & Rheumatism, 2010